Polarean Imaging Plc (POLX) - Total Liabilities

Latest as of June 2025: GBX3.19 Million GBX ≈ $387.94 USD

Based on the latest financial reports, Polarean Imaging Plc (POLX) has total liabilities worth GBX3.19 Million GBX (≈ $387.94 USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore POLX operating cash flow to assess how effectively this company generates cash.

Polarean Imaging Plc - Total Liabilities Trend (2014–2024)

This chart illustrates how Polarean Imaging Plc's total liabilities have evolved over time, based on quarterly financial data. See Polarean Imaging Plc (POLX) shareholders funds for net asset value and shareholders' equity analysis.

Polarean Imaging Plc Competitors by Total Liabilities

The table below lists competitors of Polarean Imaging Plc ranked by their total liabilities.

Company Country Total Liabilities
Plaza Centers NV
LSE:PLAZ
UK GBX162.91 Million
Becket Invest Plc
LSE:TAB
UK GBX15.38K
PTT Global Chemical Public Company Limited
F:GCB
Germany €310.60 Billion
Mingzhu Logistics Holdings Ltd
NASDAQ:YGMZ
USA $22.99 Million
The Generation Essentials Group
NYSE:TGE
USA $6.81 Million
Ptt PCL
STU:PTOG
Germany €1.67 Trillion

Liability Composition Analysis (2014–2024)

This chart breaks down Polarean Imaging Plc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see POLX stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.56 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.40 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.29 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Polarean Imaging Plc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Polarean Imaging Plc (2014–2024)

The table below shows the annual total liabilities of Polarean Imaging Plc from 2014 to 2024.

Year Total Liabilities Change
2024-12-31 GBX3.65 Million
≈ $444.06
+41.23%
2023-12-31 GBX2.58 Million
≈ $314.42
-20.05%
2022-12-31 GBX3.23 Million
≈ $393.27
+15.78%
2021-12-31 GBX2.79 Million
≈ $339.66
+30.02%
2020-12-31 GBX2.15 Million
≈ $261.23
-12.37%
2019-12-31 GBX2.45 Million
≈ $298.11
+20.26%
2018-12-31 GBX2.04 Million
≈ $247.87
-39.25%
2017-12-31 GBX3.35 Million
≈ $408.04
+216.31%
2016-12-31 GBX1.06 Million
≈ $129.00
-6.09%
2015-12-31 GBX1.13 Million
≈ $137.37
-17.35%
2014-12-31 GBX1.37 Million
≈ $166.20
--

About Polarean Imaging Plc

LSE:POLX UK Medical Devices
Market Cap
$11.75K
GBX96.56 Million GBX
Market Cap Rank
#31285 Global
#1289 in UK
Share Price
GBX0.08
Change (1 day)
-20.00%
52-Week Range
GBX0.08 - GBX1.45
All Time High
GBX106.50
About

Polarean Imaging plc operates as a drug-device manufacturer and service provider for noble gas hyperpolariser devices in Canada, the United Kingdom, and the United States. The company engages in the research, development, and commercialization of novel imaging solutions with a non-invasive and radiation-free functional imaging platform. It also offers XENOVIEW, a hyperpolarized contrast agent ind… Read more